SEC Form D filing

Somite Therapeutics, Inc., 2025-11-26

An SEC Form D private-offering notice from Boston, MA, a $47,499,943 filer-stated offering target in Biotech. Filed 2025-11-26. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Somite Therapeutics, Inc. site↗ Verified via SEC Form D

AI native TechBio company building foundation models, including its DeltaStem platform, to accelerate production of human cells for cell replacement therapies such as beta cells for type 1 diabetes and satellite cells for muscular dystrophy.

Filed 2025-11-26Filed to raise $47,499,943First money in 2025-04-11Raised so far $47,499,943HQ (as filed) Boston, MASector Biotech web-verified against the company’s own siteStage (inferred) GrowthCall status Late filing
Source linked the Form D on EDGAR↗Website verified cellularintelligence.com↗Named in the filing 3 executives & directors
Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source